Daiwa Securities Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Daiwa Securities Group’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-77	Closed	-$9K	–	1309
2021 Q1	$9K	Buy	77 +4	+5%	+$473	﹤0.01%	1050
2020 Q4	$9K	Sell	73 -144	-66%	-$16.7K	﹤0.01%	1024
2020 Q3	$24K	Hold	217	–	–	﹤0.01%	980
2020 Q2	$32K	Hold	217	–	–	﹤0.01%	1001
2020 Q1	$23K	Hold	217	–	–	﹤0.01%	1001
2019 Q4	$25K	Sell	217 -27	-11%	-$3.13K	﹤0.01%	1000
2019 Q3	$28K	Sell	244 -6	-2%	-$597	﹤0.01%	983
2019 Q2	$24K	Hold	250	–	–	﹤0.01%	1001
2019 Q1	$23K	Sell	250 -23	-8%	-$1.88K	﹤0.01%	986
2018 Q4	$21K	Buy	273 +120	+78%	+$8.83K	﹤0.01%	965
2018 Q3	$12K	Hold	153	–	–	﹤0.01%	1028
2018 Q2	$15K	Hold	153	–	–	﹤0.01%	1028
2018 Q1	$12K	Buy	+153	New	+$12.4K	﹤0.01%	1024
2016 Q3	–	Sell	-500	Closed	-$53K	–	1000
2016 Q2	$53K	Buy	+500	New	+$58.1K	﹤0.01%	871

Daiwa Securities Group's CBPO Position: Q2 2021 in Review

Daiwa Securities Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 77 shares — an estimated $9K sold.

Daiwa Securities Group first reported a position in CBPO in Q2 2016 and held it in 14 quarters. The position peaked at $53K in Q2 2016. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Daiwa Securities Group reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Daiwa Securities Group sold 77 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $9K.
Daiwa Securities Group first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and held it in 14 quarters.
Daiwa Securities Group's China Biologic Products Holdings, Inc. position peaked at $53K in Q2 2016.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Daiwa Securities Group's 13F filing for Q2 2021, filed 6 Aug 2021.